Showing results (41-50 of 56) with videos related to
Sort By:
Pageof 6
Nature Communications|December 23, 2014
Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genesSaravana M Dhanasekaran, O Alejandro Balbin, Guoan Chen, et al.Cancer Discovery|April 6, 2013
Identification of targetable FGFR gene fusions in diverse cancersYi-Mi Wu, Fengyun Su, Shanker Kalyana-Sundaram, et al.JCO Precision Oncology|August 25, 2020
Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain TumorsCarl Koschmann, Yi-Mi Wu, Chandan Kumar-Sinha, et al.Nature Genetics|November 5, 2013
Activating ESR1 mutations in hormone-resistant metastatic breast cancerDan R Robinson, Yi-Mi Wu, Pankaj Vats, et al.Acta Neuropathologica Communications|July 28, 2018
Medulloblastoma therapy generates risk of a poorly-prognostic H3 wild-type subgroup of diffuse intrinsic pontine glioma: a report from the International DIPG RegistryHunter C Gits, Maia Anderson, Stefanie Stallard, et al.The American Journal of Surgical Pathology|October 5, 2018
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the KidneyLisha Wang, Yuping Zhang, Ying-Bei Chen, et al.JAMA Oncology|February 25, 2021
Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid TumorsErin F Cobain, Yi-Mi Wu, Pankaj Vats, et al.Nature|August 8, 2017
Integrative clinical genomics of metastatic cancerDan R Robinson, Yi-Mi Wu, Robert J Lonigro, et al.JAMA|September 2, 2015
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in YouthRajen J Mody, Yi-Mi Wu, Robert J Lonigro, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|September 2, 2017
Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumorsBernard L Marini, Lydia L Benitez, Andrew H Zureick, et al.Pageof 6